| |
| |
|
| Insider
Information: |
Goater Jeff |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
64,705 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$546,110 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
64,705 |
|
|
| Total
Value |
$546,110 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
3
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
-3.0
|
| Percentage
Gain/Loss : |
 190.4%
|
 -166.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Voyager Therapeutics, Inc. |
VYGR |
Officer |
2015-11-10 |
64,705 |
|
0 |
Premium* |
|
|
Surface Oncology, Inc. |
SURF |
Director |
2023-09-08 |
0 |
2020-02-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
15 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SURF |
Surface Oncology, Inc. |
Director |
– • – |
2023-09-08 |
4 |
D |
$0.00 |
$0 |
D/D |
(129,222) |
0 |
0 |
- |
|
| SURF |
Surface Oncology, Inc. |
Director |
– • – |
2021-07-21 |
4 |
S |
$6.10 |
$779,446 |
D/D |
(127,778) |
129,222 |
0 |
% |
|
| SURF |
Surface Oncology, Inc. |
Director |
– • – |
2021-06-11 |
4 |
S |
$7.61 |
$116,226 |
D/D |
(15,273) |
257,000 |
0 |
% |
|
| SURF |
Surface Oncology, Inc. |
Director |
– • – |
2021-06-11 |
4 |
OE |
$4.14 |
$42,530 |
D/D |
10,273 |
272,273 |
0 |
- |
|
| SURF |
Surface Oncology, Inc. |
Director |
– • – |
2021-06-10 |
4 |
S |
$7.66 |
$1,798,619 |
D/D |
(234,727) |
262,000 |
0 |
% |
|
| SURF |
Surface Oncology, Inc. |
Director |
– • – |
2021-06-10 |
4 |
OE |
$4.14 |
$971,770 |
D/D |
234,727 |
496,727 |
0 |
- |
|
| SURF |
Surface Oncology, Inc. |
Chief Executive Officer |
• • – |
2021-02-08 |
4 |
AS |
$12.50 |
$31,250 |
D/D |
(2,500) |
262,000 |
0 |
% |
|
| SURF |
Surface Oncology, Inc. |
Chief Executive Officer |
• • – |
2021-02-08 |
4 |
OE |
$3.18 |
$7,950 |
D/D |
2,500 |
264,500 |
0 |
- |
|
| SURF |
Surface Oncology, Inc. |
Chief Executive Officer |
• • – |
2021-02-01 |
4 |
AS |
$10.69 |
$26,718 |
D/D |
(2,500) |
262,000 |
0 |
% |
|
| SURF |
Surface Oncology, Inc. |
Chief Executive Officer |
• • – |
2021-02-01 |
4 |
OE |
$3.18 |
$7,950 |
D/D |
2,500 |
264,500 |
0 |
- |
|
| SURF |
Surface Oncology, Inc. |
Chief Executive Officer |
• • – |
2021-01-19 |
4 |
AS |
$13.00 |
$65,000 |
D/D |
(5,000) |
262,000 |
0 |
% |
|
| SURF |
Surface Oncology, Inc. |
Chief Executive Officer |
• • – |
2021-01-19 |
4 |
OE |
$3.18 |
$15,900 |
D/D |
5,000 |
267,000 |
0 |
- |
|
| SURF |
Surface Oncology, Inc. |
Chief Executive Officer |
• • – |
2020-02-05 |
4 |
B |
$3.23 |
$16,150 |
D/D |
5,000 |
262,000 |
2.81 |
% |
|
| SURF |
Surface Oncology, Inc. |
Chief Executive Officer |
• • – |
2020-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
257,000 |
257,000 |
0 |
- |
|
| VYGR |
Voyager Therapeutics, Inc... |
SVP Finance, Bus. DevelopmentO |
• – – |
2015-11-10 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
64,705 |
|
- |
|
15 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
